Exact Mass: 436.99170900000007

Exact Mass Matches: 436.99170900000007

Found 24 metabolites which its exact mass value is equals to given mass value 436.99170900000007, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Picosulfuric acid

{4-[(pyridin-2-yl)[4-(sulphooxy)phenyl]methyl]phenyl}oxidanesulphonic acid

C18H15NO8S2 (437.023907)


   

tigemonam

2-{[({[2,2-dimethyl-4-oxo-1-(sulphooxy)azetidin-3-yl]carbamoyl}(2-imino-2,3-dihydro-1,3-thiazol-4-yl)methylidene)amino]oxy}acetic acid

C12H15N5O9S2 (437.03111800000005)


   

[2-(Pyridin-2-ylmethyl)-4-(4-sulfooxyphenyl)phenyl] hydrogen sulfate

{3-[(pyridin-2-yl)methyl]-4-(sulphooxy)-[1,1-biphenyl]-4-yl}oxidanesulphonic acid

C18H15NO8S2 (437.023907)


   
   

Tigemonam

Tigemonam

C12H15N5O9S2 (437.03111800000005)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

3-Iodo-1-trityl-1H-1,2,4-triazole

3-Iodo-1-trityl-1H-1,2,4-triazole

C21H16IN3 (437.0388926)


   
   

Epacadostat

4-[[2-[(Aminosulfonyl)amino]ethyl]amino]-N-(3-bromo-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide

C11H13BrFN7O4S (436.99170900000007)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C308 - Immunotherapeutic Agent > C141144 - Immune Checkpoint Modulator C471 - Enzyme Inhibitor > C141137 - IDO1 Inhibitor C274 - Antineoplastic Agent

   
   

Cerium Acetyl Acetonate

Cerium Acetyl Acetonate

C15H21CeO6 (437.0392486)


   
   
   

ETHYL 5-(4-CHLOROPHENYL)-4-(CHLOROSULFONYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE

ETHYL 5-(4-CHLOROPHENYL)-4-(CHLOROSULFONYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE

C20H17Cl2NO4S (437.02553020000005)


   

(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]-2-propenoic acid

(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]-2-propenoic acid

C22H16BrNO4 (437.02626360000005)


   
   

2-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-7-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidine

2-[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-7-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidine

C18H11ClF3N5OS (437.03249020000004)


   

2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[(2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl)amino]-2-oxoethylidene]amino]oxyacetic acid

2-[(E)-[1-(2-amino-1,3-thiazol-4-yl)-2-[(2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl)amino]-2-oxoethylidene]amino]oxyacetic acid

C12H15N5O9S2 (437.03111800000005)


   

Motualevic acid A

Motualevic acid A

C16H25Br2NO3 (437.02010600000006)


An enamide obtained by the formal condensation of the amino group of glycine with the carboxy group of 14,14-dibromotetradeca-2,13-dienoic acid (the 2E stereoisomer). It is isolated from the marine sponge Siliquariaspongia sp. and exhibits antibacterial properties.

   

N-(2,2,2-trichloro-1-diethoxyphosphorylethyl)-1-naphthalenecarboxamide

N-(2,2,2-trichloro-1-diethoxyphosphorylethyl)-1-naphthalenecarboxamide

C17H19Cl3NO4P (437.0117234000001)


   

{5-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoyl}(methylsulfonyl)azanide

{5-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoyl}(methylsulfonyl)azanide

C15H9ClF3N2O6S- (436.982194)


   
   

[4-Hydroxy-7-(sulooxymethyl)-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

[4-Hydroxy-7-(sulooxymethyl)-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

C18H13O11S+ (437.0178568)